LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 79.34 | 84.90 | 3 | 9051 | 0.0003 | -0.3912 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 79.34 | 84.90 | 4841 | 9051 | 0.5348 | 0.8226 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 79.34 | 84.90 | 786 | 9051 | 0.0868 | 0.3915 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 79.34 | 84.90 | 9201 | 9051 | 1.0165 | 1.0049 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.05 | 84.90 | 3 | 8863 | 0.0003 | -0.3925 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.05 | 84.90 | 4848 | 8863 | 0.5469 | 0.8279 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.05 | 84.90 | 721 | 8863 | 0.0813 | 0.3757 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 81.05 | 84.90 | 9492 | 8863 | 1.0709 | 1.0205 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.75 | 84.90 | 2 | 8621 | 0.0002 | -0.4301 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.75 | 84.90 | 5120 | 8621 | 0.5939 | 0.8496 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.75 | 84.90 | 666 | 8621 | 0.0772 | 0.3621 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 82.75 | 84.90 | 9742 | 8621 | 1.1300 | 1.0370 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.45 | 84.90 | 3 | 8254 | 0.0004 | -0.3972 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.45 | 84.90 | 5106 | 8254 | 0.6186 | 0.8597 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.45 | 84.90 | 647 | 8254 | 0.0784 | 0.3601 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 84.45 | 84.90 | 10008 | 8254 | 1.2124 | 1.0592 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.16 | 84.90 | 3 | 8141 | 0.0004 | -0.3982 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.16 | 84.90 | 5590 | 8141 | 0.6866 | 0.8890 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.16 | 84.90 | 544 | 8141 | 0.0668 | 0.3260 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.16 | 84.90 | 10238 | 8141 | 1.2574 | 1.0708 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 84.90 | 3 | 7680 | 0.0004 | -0.4021 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 84.90 | 5399 | 7680 | 0.7030 | 0.8944 | MN20160318_Q02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 84.90 | 577 | 7680 | 0.0751 | 0.3429 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 87.86 | 84.90 | 10514 | 7680 | 1.3689 | 1.0990 | MN20160318_Q02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 89.57 | 84.90 | 7 | 7494 | 0.0009 | -0.3203 | MN20160318_Q02 | H17 |